Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
About
CombiMatrix Corporation is a biotechnology company. The Company develops technology to produce DNA arrays for use in identifying and determining the roles of genes, gene mutations, and proteins which is used in genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences, and nanotechnology.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is 'cheap' on EV/EBITDA.
Data is available to registered users only
Buy
Sell